• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

ICEID: S. Aureus Pneumonia May Be Increasing Problem

Article

Community-acquired pneumonia caused by the Staphylococcus aureus bacterium has been estimated to account for 3 percent to 5 percent of all cases, but the actual figure may be significantly higher and may include infections caused by methicillin-resistant S. aureus strains, according to research presented this week at the 2008 International Conference on Emerging Infectious Diseases in Atlanta.

<p>THURSDAY, March 20 (HealthDay News) -- Community-acquired pneumonia (CAP) caused by the <i>Staphylococcus aureus</i> bacterium has been estimated to account for 3 percent to 5 percent of all cases, but the actual figure may be significantly higher and may include infections caused by methicillin-resistant <i>S. aureus</i> (MRSA) strains, according to research presented this week at the 2008 International Conference on Emerging Infectious Diseases in Atlanta.</p><p>Alexander Kallen, M.D., of the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues reviewed the charts of 249 patients who were admitted to one of the three Atlanta children's hospitals from October 1, 2006 to April 1, 2007 with <i>S. aureus</i> from a sterile site or respiratory specimen.</p><p>The researchers identified 53 episodes of <i>S. aureus</i> CAP, including 48 episodes of primary CAP. Of the primary CAP episodes, 46 percent were MRSA. They included 37 (77 percent) patients with prior medical diagnoses and 18 with cystic fibrosis.</p><p>"Coverage for MRSA should be considered in children, particularly those with underlying medical conditions, admitted with CAP during the influenza season," the authors conclude.</p><p><a href="http://www.asm.org/ASM/files/LeftMarginHeaderList/DOWNLOADFILENAME/000000002747/2008%20ICEID%20program.pdf" target="_new">Abstract -- Board 301</a><br/><a href="http://www.asm.org/ASM/files/LeftMarginHeaderList/DOWNLOADFILENAME/000000002754/mrsa%20cap.pdf" target="_new">More Information</a></p>

Copyright © 2008 <a href="http://www.physiciansbriefing.com/" target="_new">ScoutNews, LLC</a>. All rights reserved.

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.